|Articles|December 1, 2009
- BioPharm International-12-01-2009
- Volume 22
- Issue 12
BioPharm International, December 2009 (PDF)
QbD in Practice–Part 2: The Regulatory Filing
Advertisement
Articles in this issue
about 16 years ago
CDMOs Benefit from the Growing Biologics Marketabout 16 years ago
Disposables in Rapid Response Manufacturing: The Next Stepsabout 16 years ago
Quality by Design for Biotechnology Products—Part 2about 16 years ago
Licensing of Expression Systemsabout 16 years ago
The Promise and Perils of Vaccinesabout 16 years ago
Speeding Up Slowlyabout 16 years ago
Freeze-Thaw Performance and Robustness Assessment of Celsius FFT 6Labout 16 years ago
Faking ItNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
Charles River Incubator Cohort to Accelerate CGT Development
4
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
5
